as on February 21, 2026 at 7:59 am IST
Day's Low
Day's High
4.23%
Downside
1.73%
Upside
52 Week's Low
52 Week's High
45.64%
Downside
35.43%
Upside
Check Charles River Laboratories International market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.1B
EPS (TTM)
10.96
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.17%
PE Ratio (TTM)
23.31
Industry PE ratio
18.238589743589742
PEG Ratio
0.1185
EBITDA
804.4M
Revenue (TTM)
4.0B
Profit Margin
-3.60%
Return On Equity TTM
-4.23%
Track how Charles River Laboratories International P/E has moved over time to understand its valuation trends.
Charles River Laboratories International in the last 5 years
Lowest (12.45x)
June 30, 2025
Industry (18.24x)
February 21, 2026
Today (23.31x)
February 21, 2026
Highest (40.60x)
September 30, 2021
Today’s Price to Earnings Ratio: 23.31x
Compare market cap, revenue, PE, and other key metrics of Charles River Laboratories International with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $8.1B | -41.66% | 23.31 | -3.60% | |
| BUY | $50.5B | 16.82% | 48.29 | 24.62% | |
| HOLD | $32.7B | 18.32% | 31.01 | 20.30% | |
| BUY | $193.5B | 6.7% | 29.07 | 15.05% | |
| BUY | $35.8B | -3.13% | 27.77 | 18.75% |
The Charles River Laboratories International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Charles River Laboratories International investment value today
Current value as on today
₹1,08,381
Returns
₹8,381
(+8.38%)
Returns from Charles River Laboratories International Stock
₹3,668 (+3.67%)
Dollar Returns*
₹4,713 (+4.71%)
Based on 21 analysts
61.90%
Buy
38.10%
Hold
0.00%
Sell
Based on 21 analysts, 61.9% of analysts recommend a 'BUY' rating for Charles River Laboratories International. Average target price of $199.2
Get share price movements and forecasts by analysts on Charles River Laboratories International.
What analysts predicted
15.16%UPSIDE
Target Price
$199.2
Current Price
$169
Analyzed by
21 Analysts
Target
$199.20
Charles River Laboratories International target price $199.2, a slight upside of 15.16% compared to current price of $169. According to 21 analysts rating.
Search interest for Charles River Laboratories International Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 18 February
Wed, 07:22 PM
-Glenn Coleman appointed CFO effective April 6, 2026, bringing extensive healthcare finance experience.
Wed, 07:25 PM
-CRL reports Q4 2025 adjusted EPS of $2.39, surpassing estimates, but GAAP loss of $5.62 per share.
Wed, 11:19 PM
-Shares fell 4% after disappointing 2026 revenue forecast amid challenging growth environment.
Today's Timeline - 18 February
Thu, 06:44 AM
-Charles River Laboratories reports Q4 2025 revenue of $994.23 million with a net loss of $276.56 million; new CFO appointed.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, CRL stock has moved up by 4.7%
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 40.4% return, outperforming this stock by 36.8%
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 33.5% return, outperforming this stock by 56.4%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 1.03B → 994.22M (in $), with an average decrease of 1.9% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 54.42M → -276.55M (in $), with an average decrease of 608.2% per quarter
| Organisation | Charles River Laboratories International |
| Headquarters | 251 Ballardvale Street, Wilmington, MA, United States, 01887 |
| Industry | Commercial Services |
| CEO | Mr. James C. Foster J.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Victoria L. Creamer | Corporate Executive VP & Chief People Officer |
Mr. Michael Gunnar Knell | Interim CFO, Corporate Senior VP & Chief Accounting Officer |
Mr. Todd Spencer | Corporate Vice President of Investor Relations |
Mr. Mark Mintz | Corporate EVP, Chief Information Officer & Global Shared Services |
Mr. Matthew L. Daniel J.D. | Corporate Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer |
Ms. Amy E. Cianciaruso | Corporate Senior Vice President, Chief Communications Officer & Government Relations |
Dr. Brian F. Bathgate Ph.D. | Corporate Senior Vice President of European Safety Assessment |
Mr. James C. Foster J.D. | Chairman, President & CEO |
Mr. Joseph W. LaPlume J.D. | Corporate Executive Vice President of Corporate Development & Strategy |
Prof. Julie Frearson Ph.D. | Corporate Senior VP & Chief Scientific Officer |
Charles River Laboratories International share price today is $169 as on at the close of the market. Charles River Laboratories International share today touched a day high of $171.93 and a low of $161.85.
Charles River Laboratories International share touched a 52 week high of $228.88 on and a 52 week low of $91.86 on . Charles River Laboratories International stock price today i.e. is closed at $169,which is 26.16% down from its 52 week high and 83.97% up from its 52 week low.
Charles River Laboratories International market capitalisation is $0.01T as on .
Indian investors can start investing in Charles River Laboratories International (CRL) shares with as little as ₹90.681 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.81 in Charles River Laboratories International stock (as per the Rupee-Dollar exchange rate as on ).
Based on Charles River Laboratories International share’s latest price of $169 as on February 21, 2026 at 2:29 am IST, you will get 0.0592 shares of Charles River Laboratories International. Learn more about
fractional shares .
Charles River Laboratories International stock has given -41.66% share price returns and 25.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?